Literature DB >> 7524098

Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells.

Y Aoki1, K J Isselbacher, S Pillai.   

Abstract

The gene encoding Bruton tyrosine kinase (Btk) is known to be mutated in human X chromosome-linked agammaglobulinemia and in the Xid mouse. This kinase was examined in B lymphocytes before and after antigen receptor ligation and also in pre-B cells. Btk was found to be catalytically activated and tyrosine phosphorylated in response to anti-IgM stimulation in B cells. This kinase is also constitutively phosphorylated on tyrosine residues in pre-B cells. These findings point to a functional role for Btk in pre-antigen and antigen receptor signaling during B-cell development and provide a biochemical explanation for the X-linked genetic syndromes already linked to this kinase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524098      PMCID: PMC45070          DOI: 10.1073/pnas.91.22.10606

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor.

Authors:  M R Gold; D A Law; A L DeFranco
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

2.  Formation of disulphide-linked mu 2 omega 2 tetramers in pre-B cells by the 18K omega-immunoglobulin light chain.

Authors:  S Pillai; D Baltimore
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

3.  Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.

Authors:  S M Dymecki; J E Niederhuber; S V Desiderio
Journal:  Science       Date:  1990-01-19       Impact factor: 47.728

4.  Primary sequence and developmental expression of a novel Drosophila melanogaster src gene.

Authors:  R J Gregory; K L Kammermeyer; W S Vincent; S G Wadsworth
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

5.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.

Authors:  D J Rawlings; D C Saffran; S Tsukada; D A Largaespada; J C Grimaldi; L Cohen; R N Mohr; J F Bazan; M Howard; N G Copeland
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

6.  itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.

Authors:  J D Siliciano; T A Morrow; S V Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

7.  Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development.

Authors:  A Ehlich; S Schaal; H Gu; D Kitamura; W Müller; K Rajewsky
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

8.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

9.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Authors:  S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  The omega/lambda 5 surrogate immunoglobulin light chain is expressed on the surface of transitional B lymphocytes in murine bone marrow.

Authors:  B J Cherayil; S Pillai
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  52 in total

Review 1.  Ligand-dependent and -independent processes in B-cell-receptor-mediated signaling.

Authors:  E M Fuentes-Pananá; J G Monroe
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.

Authors:  S Nisitani; R M Kato; D J Rawlings; O N Witte; M I Wahl
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 3.  Clinical consequences of defects in B-cell development.

Authors:  Andre M Vale; Harry W Schroeder
Journal:  J Allergy Clin Immunol       Date:  2010-04       Impact factor: 10.793

4.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas.

Authors:  Shariful Islam; Wenqing Qi; Carla Morales; Laurence Cooke; Catherine Spier; Eric Weterings; Daruka Mahadevan
Journal:  Mol Cancer Ther       Date:  2017-06-14       Impact factor: 6.261

Review 6.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

7.  B-cell-specific demethylation of BTK, the defective gene in X-linked agammaglobulinemia.

Authors:  O Parolini; J Rohrer; L H Shapiro; M E Conley
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.

Authors:  G M Dingjan; A Maas; M C Nawijn; L Smit; J S Voerman; F Grosveld; R W Hendriks
Journal:  EMBO J       Date:  1998-09-15       Impact factor: 11.598

9.  Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.

Authors:  Jaya Rajaiya; Melissa Hatfield; Jamee C Nixon; David J Rawlings; Carol F Webb
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies.

Authors:  Sabine Ponader; Jan A Burger
Journal:  J Clin Oncol       Date:  2014-04-28       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.